Raschella et al. reported that B-Myb is overexpressed in neuroblastoma tumors, and that high expression level of B-Myb is an independent prognostic factor for poor neuroblastoma tumor patient survival [18]. This evidence concerns the gene MYBL2 and neoplasm.